Our previous study indicated that de-ubiquitinase USP39 and E3 ligase TRIM26 function in an antagonistic but not a competitive pattern, and play key roles in controlling ZEB1 stability to determine the HCC progression [19]. Here, USP39 is linked to hepatocellular carcinoma.